Production (Stage)
Aldeyra Therapeutics, Inc.
ALDX
$2.22
-$0.03-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 90.06M | 101.15M | 72.74M | 80.33M | 83.04M |
| Total Receivables | 755.50K | -- | 40.00M | 40.00M | 50.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 473.30K | 709.20K | 1.15M | 1.46M | 490.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.44M | 2.21M | 2.83M | 3.86M | 7.32M |
| Total Current Assets | 92.73M | 104.07M | 116.72M | 125.65M | 140.85M |
|
|
|||||
| Total Current Assets | 92.73M | 104.07M | 116.72M | 125.65M | 140.85M |
| Net Property, Plant & Equipment | 466.90K | 267.00K | 331.30K | 394.30K | 455.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 267.30K | 267.30K | -- | -- |
| Total Assets | 93.20M | 104.61M | 117.32M | 126.04M | 141.30M |
|
|
|||||
| Total Accounts Payable | 346.10K | 180.50K | 186.90K | 254.40K | 280.30K |
| Total Accrued Expenses | 7.68M | 12.12M | 10.42M | 5.84M | 5.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 255.30K | 303.00K | 543.20K | 15.50M | 15.45M |
| Total Finance Division Other Current Liabilities | 6.00M | 6.00M | 6.00M | 6.00M | -- |
| Total Other Current Liabilities | 6.00M | 6.00M | 6.00M | 6.00M | -- |
| Total Current Liabilities | 14.29M | 18.60M | 17.15M | 27.59M | 21.68M |
|
|
|||||
| Total Current Liabilities | 14.29M | 18.60M | 17.15M | 27.59M | 21.68M |
| Long-Term Debt | 15.10M | 15.00M | 15.00M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 212.80K | -- | 70.20K | 138.90K | 206.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 6.00M |
| Total Liabilities | 29.60M | 33.60M | 32.22M | 27.73M | 27.88M |
|
|
|||||
| Common Stock & APIC | 523.64M | 521.08M | 519.33M | 517.51M | 515.76M |
| Retained Earnings | -460.04M | -450.11M | -434.30M | -419.19M | -402.34M |
| Treasury Stock & Other | 1.60K | 37.40K | 66.50K | -9.70K | -3.00K |
| Total Common Equity | 63.60M | 71.00M | 85.10M | 98.31M | 113.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 63.60M | 71.00M | 85.10M | 98.31M | 113.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 63.60M | 71.00M | 85.10M | 98.31M | 113.42M |
|
|
|||||